Kristian Stensland, MD, MPH, MS

 Kristian D. Stensland
Assistant Professor of Urology
Assistant Professor of Learning Health Sciences
Medical School
Office:
University of Michigan
Department of Urology
NCRC Building 16; 2800 Plymouth Road
Ann Arbor, Michigan 48109
Available to mentor
Kristian Stensland, MD, MPH, MS
Kristian D. Stensland
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications

  • Manage Your Profile

    • About

    Dr. Kristian Stensland is a urologic oncologist and health services researcher. His research focuses on improving the conduct, efficiency, and equity of clinical trials through informatics, infrastructure, and implementation science.

    Qualifications
    • MS, Health Infrastructures and Learning Systems
      University of Michigan, Ann Arbor, MI, United States
      2020 - 2021
    • MPH, Quantitative Methods
      Harvard TH Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, United States
      2016 - 2017
    • MD, Distinction in Research
      Icahn School of Medicine at Mount Sinai, 1 Gustave L Levy Place, New York, NY, 10029, United States
      2009 - 2014
    • BA, Spanish Literature, Chemistry
      Vanderbilt University, Nashville, TN, United States
      2005 - 2009

    Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    • Center Member
      AI and Digital Health Innovation
    • Center Member
      Rogel Cancer Center

    Research Overview

    My research focuses on improving the conduct, efficiency, and equity of clinical trials through informatics, infrastructure, and implementation science.

    Recent Publications

     See All Publications
    • Journal Article
      Survivor-identified barriers and facilitators to acute phase recovery following radical cystectomy
      Marchetti KA, Asees A, Bokil AP, Medich M, Durica KC, Rieker J, Rak K, Borza T, Alcorn ML, Davies BJ, Low CA, Stensland KD, Jacobs BL. Urologic Oncology Seminars and Original Investigations, 2026 Jul 1; 44 (7): 234 - 242. DOI:10.1016/j.urolonc.2026.04.293
      PMID: 42150484
    • Proceeding / Abstract / Poster
      Precision Feedback to Drive Engagement with a Process Measure Dashboard: A Randomized Stepped Wedge Trial
      Lewicki P, Wang B, Daignault-Newton S, Ross J, Salka B, Krumm A, Ghani K, Dauw C, Landis-Lewis Z, Stensland K. 2026 Jun 22;
    • Presentation
      Clinical Trial Investigation Across Different Practice Settings: Resources, Review Processes, and Patient Recruitment
      2026 May 10;
    • Journal Article
      IP37-18 LOWER URINARY TRACT SYMPTOM IMPROVEMENT AFTER FOCAL IRREVERSIBLE ELECTROPORATION FOR LOCALIZED PROSTATE CANCER: 12-MONTH PRESERVE TRIAL RESULTS
      Lokeshwar SD, Ramirez J, Aronowitz S, Ayenew M, Miocinovic R, Patel AR, Lomas DJ, Correa AF, Chen DYT, Rastinehad AR, Schwartz MJ, Sidana A, Stensland KD, Helfand BT, Gahan JC, Meng X, Yu A, Brisbane WG, Vourganti S, Barqawi AB, Uchio EM, Wysock JS, Polascik TJ, Mcclure TD, Fainberg J, Coleman JA, George AK. Journal of Urology, 2026 Apr 30; 215 (5S): e783 DOI:10.1097/01.ju.0001191504.60654.49.18
    • Journal Article
      IP37-19 IMPACT OF IRREVERSIBLE ELECTROPORATION ON SEXUAL FUNCTION: AN ANALYSIS OF THE PRESERVE TRIAL
      Lokeshwar SD, Ramirez J, Aronowitz S, Ayenew M, Miocinovic R, Patel AR, Lomas DJ, Correa AF, Chen DYT, Rastinehad AR, Schwartz MJ, Sidana A, Stensland KD, Helfand BT, Gahan JC, Meng X, Yu A, Brisbane WG, Vourganti S, Barqawi AB, Uchio EM, Wysock JS, Polascik TJ, Mcclure TD, Fainberg J, Coleman JA, George AK. Journal of Urology, 2026 Apr 30; 215 (5S): e783 DOI:10.1097/01.ju.0001191504.60654.49.19
    • Journal Article
      Editorial Commentary.
      Krischak M, Stensland K. Urol Pract, 2026 Mar; 13 (2): 129 DOI:10.1097/UPJ.0000000000000927
      PMID: 41329825
    • Journal Article
      Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial
      George AK, Miocinovic R, Patel AR, Lomas DJ, Correa AF, Chen DYT, Rastinehad AR, Schwartz MJ, Sidana A, Stensland KD, Helfand BT, Gahan JC, Meng X, Yu A, Brisbane WG, Vourganti S, Barqawi AB, Uchio EM, Wysock JS, Polascik TJ, McClure TD, Fainberg J, Coleman JA. European Urology, 2026 Jan 1; 89 (1): 57 - 68. DOI:10.1016/j.eururo.2025.06.003
      PMID: 40685282
    • Journal Article
      Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer
      Miller SR, Chung DH, Gonzalez RT, Jackson WC, Caram MEV, Tsao PA, Stensland K, Gulati R, Shah Y, Wale D, Elliott D, Caverly T, Hofer TP, Saini S, Green MD, Schipper M, Dess RT, Bryant AK. Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2025 Dec 3; 66 (12): 1891 - 1897. DOI:10.2967/jnumed.125.270825
      PMID: 41101975

    Featured News & Stories

         microscope drawing in navy and yellow with off white background
    Health Lab

    Model predicts long term mortality risk from prostate cancer

    Existing risk calculators for prostate cancer have less accurate estimates or predict risk through tests based on biopsy, which requires tissue samples and extra processing times. U-M researchers have developed a new model that can help doctors and patients understand their PSA results and what it means for patient life expectancy.